Induction of EMT by Twist Proteins as a Collateral Effect of Tumor-Promoting Inactivation of Premature Senescence

Stéphane Ansieau, Jérémy Bastid, Agnès Doreau, +13

Cancer Cell

MedicineCancer GrowthEpithelial-mesenchymal InteractionsCellular SenescenceCell Biology +9

Interleukin 17 acts in synergy with B cell–activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus

Agnès Doreau, Alexandre Belot, Jérémy Bastid, +14

Nature Immunology

Immune RegulationImmunologyImmune DysregulationInflammationB Cell Biology +15

Blocking Antibodies Targeting the CD39/CD73 Immunosuppressive Pathway Unleash Immune Responses in Combination Cancer Therapies

Ivan Perrot, Henri‐Alexandre Michaud, Marc Giraudon-Paoli, +23

Cell Reports

Cancer ImmunosurveillanceMedicineImmune Checkpoint InhibitorsImmunologyTumor Immunity +13

Inhibition of CD39 Enzymatic Function at the Surface of Tumor Cells Alleviates Their Immunosuppressive Activity

Jérémy Bastid, Anne Regairaz, Nathalie Bonnefoy, +13

Cancer Immunology Research

Cd39 Enzymatic FunctionT-regulatory CellImmunologyImmune RegulationImmunoediting +23

IL-17A is produced by breast cancer TILs and promotes chemoresistance and proliferation through ERK1/2

Stéphanie Cochaud, Jérôme Giustiniani, Clémence Thomas, +10

Scientific Reports

Regulatory T Cells from Colon Cancer Patients Inhibit Effector T-cell Migration through an Adenosine-Dependent Mechanism

Patrik Sundström, Hanna Stenstad, Veronica Langenes, +8

Cancer Immunology Research

IL-17A and its homologs IL-25/IL-17E recruit the c-RAF/S6 kinase pathway and the generation of pro-oncogenic LMW-E in breast cancer cells

Sarah Mombelli, Stéphanie Cochaud, Yacine Merrouche, +9

Scientific Reports

The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway

Emilie Laprévotte, Stéphanie Cochaud, Stanislas du Manoir, +14

Oncotarget

<scp>CD</scp>39 is involved in mediating suppression by <i><scp>M</scp>ycobacterium bovis</i><scp>BCG</scp>‐activated human <scp>CD</scp>8⁺<scp>CD</scp>39⁺ regulatory <scp>T</scp> cells

Mardi C. Boer, Krista E. van Meijgaarden, Jérémy Bastid, +2

European Journal of Immunology

Lymphocyte-derived interleukin-17A adds another brick in the wall of inflammation-induced breast carcinogenesis

Jérémy Bastid, Nathalie Bonnefoy, Jean‐François Eliaou, +1

OncoImmunology